Aflac Stock Plunges 1.49% as $0.27 Billion Trading Volume Ranks 406th Amid Affirmed Top-Tier Credit Ratings

On September 5, 2025, , , , ranking 406th in the market. affirmed Aflac’s Financial Strength Rating of A+ (Superior) and Long-Term Issuer Credit Ratings of “aa” (Superior) for its subsidiaries, citing strong balance sheet strength, operating performance, and risk management. The agency highlighted Aflac’s robust capitalization, measured by Best’s Capital Adequacy Ratio, and its ability to maintain solid risk-based capital levels in the U.S. and Japan. Aflac’s equity growth, driven by consistent earnings, and its diversified investment portfolio further support its credit profile.

The ratings also reflect Aflac’s favorable market positions in Japan and the U.S., where it remains a leader in supplemental insurance. Despite a recent decline in premiums due to slower sales and policy maturity trends, , fueled by increased U.S. sales and new cancer product offerings in Japan. Aflac’s enterprise risk management () framework is a key strength, with comprehensive processes to identify and mitigate risks across its operations. This, combined with access to substantial credit facilities and intercompany agreements, enhances its financial flexibility.

At the moment, the built-in back-testing tools I can invoke are designed for a single security (or a predefined index/ETF). Your request involves constructing and rebalancing a 500-stock portfolio every trading day, which requires a custom multi-asset engine that is not directly exposed through the current tool set. To move forward, I can explore two practical alternatives: 1. Proxy approach – use a representative, liquid index or ETF and back-test a daily “in/out” strategy on that single instrument. 2. Custom approach – export the necessary raw data for offline simulation in external tools like Python/R. Please indicate your preferred path for further action.